Oberweis Asset Management Inc Inogen Inc Transaction History

Oberweis Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $2.61 Million - $5.54 Million	-23,095 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$189.1 - $282.92 $1.15 Million - $1.72 Million	-6,080 Reduced 20.84%	23,095 $5.64 Million
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $1.8 Million - $2.79 Million	-14,510 Reduced 33.22%	29,175 $5.44 Million
Q1 2018 May 15, 2018	SELL	$114.22 - $133.22 $757,849 - $883,914	-6,635 Reduced 13.19%	43,685 $5.37 Million
Q4 2017 Feb 14, 2018	SELL	$93.4 - $128.74 $756,540 - $1.04 Million	-8,100 Reduced 13.87%	50,320 $5.99 Million
Q3 2017 Nov 13, 2017	BUY	$91.08 - $104.49 $5.32 Million - $6.1 Million	58,420	58,420 $5.56 Million

145

20.8M

88.5K

116K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $166M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.